Enhanced periodontal regeneration using formulated injectable hyaluronic acid with or without PRP: A rat ligature model Authors: Wafaa Yahia Alghonemy, Nevien M Ahmed, Abeer A Abou Samra, Omnia M Abdelfatah, Rania A Hanafy, Asmaa M Abd El-Aziz, Eman M Salem Published: 2026 ABSTRACT AbstractObjectiveTo evaluate the regenerative effects of platelet-rich plasma (PRP) combined with 3% low-molecular-weight hyaluronic acid (HA) gel in treating ligature-induced periodontitis in rats.Methods•40 male albino rats divided into 5 groups: Control (no treatment), Periodontitis only, Periodontitis + HA, Periodontitis + PRP, Periodontitis + HA + PRP.•After 2 weeks, histological (light microscopy and SEM) and biochemical (TNF-α, IL-1β) evaluations were performed.ResultsHistological and SEM examinations showed structural damage in the periodontitis group, including pocket formation and disorganized bone. Inflammatory markers (TNF-α and IL-1β) were significantly higher in this group than in the control group. Treatment with HA, PRP, and especially their combination significantly reduced these markers. The combined therapy (Group V) showed the most effective recovery, while HA (Group III) and PRP (Group IV) alone led to partial improvement.ConclusionTreatment modalities that include HA or PRP administration could improve periodontal healing. However, the combined administration of HA and PRP yielded superior histological and statistical outcomes. This might be due to the intensifying collection of the adjunctives' anti-inflammatory and regenerative properties. However, additional studies are needed to evaluate this combination.Keywords: Platelet-rich plasma, Hyaluronic acid, Periodontitis, Histological features, Interleukin-1β, Tumor necrosis factor-α Introduction Periodontitis is an inflammatory condition that affects the tooth-supporting structures, causing tissue destruction and tooth loss through the interaction between periodontopathogenic bacteria in dental plaque and the host immune response.1 One of its essential sequelae is advanced alveolar bone loss, which supports the teeth and leads to tooth mobility and loss.2 Periodontitis develops in response to pro-inflammatory cytokines such as TNF-α and interleukin-1β (IL-1β). By activating osteoclasts and stimulating the production of mediators linked to bone degradation, IL-1β and TNF-α contribute to bone resorption.3,4 Histologically, periodontitis is characterized by apical relocation of the periodontal ligament (PDL) attachment, connective tissue (CT) destruction, and resorption of the alveolar bone.5 Conventional periodontal therapy relies on mechanical debridement, such as scaling and root planing, to remove bacterial plaque and calculus from periodontal pockets.6 In addition, surgical periodontal treatment might be necessary for persistent deep pockets with severe periodontitis.7 However, in some cases, delayed healing or even failure of primary healing, dehiscence of the gingival flap, and bacterial growth could develop.8 Thus, researchers recently used certain autologous products in regenerative periodontal treatment to accelerate and improve the success of periodontitis treatment by avoiding immunogenic reactions and disease transmission between individuals.9,10 Platelet-rich plasma (PRP) is an autologous product considered an easily accessible source of growth factors to support and accelerate bone and soft tissue healing.11,12 PRP plays a significant role in periodontal treatment through its anti-inflammatory effects when injected into a deeper periodontal pocket formed by periodontitis.13 They found that all clinical periodontal parameters decreased. However, periodontal injections of PRP during orthodontic treatment did not demonstrate significant advantages over conventional methods for bleeding on probing, pocket depth, clinical attachment level, or gingival recession.14 Recent research found that cell therapy combined with PRP for periodontal tissue regeneration significantly improves the effectiveness of periodontitis treatment compared with PRP alone, especially when combined with stem cells.15 Hyaluronic acid (HA) is a crucial constituent of the PDL matrix. It is essential for cell adhesion, migration, and differentiation, processes that are mediated by cell surface receptors and HA-binding proteins. Moreover, it has a fundamental role in tissue growth, development, and repair.16 Furthermore, subgingival administration of HA gel, as an adjunct to surface root debridement, exhibits significant anti-inflammatory properties. This approach shows potential for managing periodontitis, with a significant positive impact on clinical periodontal parameters, pro-inflammatory cytokines, and biochemical markers, compared with chlorhexidine. Therefore, the localized application of HA gel within periodontal pockets may be advocated as a complementary therapy to SRD for the management of periodontitis, particularly in patients with chlorhexidine hypersensitivity and those undergoing periodontal maintenance therapy.17 18Another study evaluated the effect of HA gel after scaling and root planning in patients with periodontitis. They found a significant decrease in mean pocket depth and clinical attachment level18; nevertheless, it was concluded that the assistant's use of HA in the treatment of periodontitis improved inflammatory reactions, periodontal pocket depth, and clinical attachment level at different follow-up periods.19 Recently, an investigation was conducted into the effectiveness of combining freeze-dried PRP with HA in promoting periodontal surgical healing in an animal model. The results suggested that the PRP-HA acid combination accelerated tissue regeneration and enhanced healing compared to controls. The study highlighted improved tissue repair, reduced inflammation, and better clinical outcomes post-surgery, and concluded that this combination could be a promising therapeutic option for periodontal regeneration.20 Thus, the current study aimed to evaluate the therapeutic effect of platelet-rich plasma (PRP) versus a locally formulated low-molecular-weight hyaluronic acid (HA) gel and to assess whether combining both adjuncts provides superior regenerative outcomes compared to their individual use. The null hypothesis states that the combination of formulated HA and PRP will not result in significantly greater periodontal healing than either adjunctive used alone. Materials and methods Ethical approval All experimental procedures were conducted in accordance with the ARRIVE guidelines and the Institutional Animal Care and Use Committee (IACUC) regulations. The experimental protocol was reviewed and approved by the Research Ethics Committee of the Faculty of Dentistry, Pharos University, under ethical code PUA02202402253192, ensuring that all procedures minimized animal suffering and adhered to national and institutional standards for the care and use of laboratory animals. Sample size calculation The minimal sample size was calculated using data from a previous study20 The sample size was calculated based on the effectiveness of periodontitis treatment. Based on Wulandari et al.20 Results, adopting a power of 80% (β = 0.20) to detect a standardized effect size in the bleeding on probing (primary outcome) of 0.745 and a level of significance of 5% (α error accepted = 0.05), the minimum required sample size was found to be 8 specimens per group (Total sample size 40 specimens).21 Any specimen loss from the study sample due to a processing error will be replaced to maintain the sample size.22 Group assignment and animal preparation Forty male albino rats aged 8-10 weeks (200-250 g) with regular dentition were acquired from the Faculty of Agriculture, Alexandria University. The rats were selected 2 weeks before the experiment and inspected to exclude any general or dental diseases. The animals received water and food throughout the experimental period and were housed in a controlled-temperature, controlled-light environment, in accordance with the ARRIVE guidelines.23 Before doing periodontitis treatment, the procedures were performed under general anesthesia through intramuscular injection of 0. 4 ml/kg of atropine sulfate as a premedication drug followed by an infusion of a mixture of xylazine 2% (Adwia, 10th of Ramadan City, Egypt) and ketamine hydrochloride 10% (ketamine alfasan10%, Woerden, The Netherlands) at a dose of 0.2 and 0.5 ml/kg body weight, respectively. A total of 40 rats were randomly categorized into 5 groups (n = 8 rats per group): •Group I (control) without any intervention or treatment Group I (control) without any intervention or treatment •Group II (periodontitis) ligature-induced periodontitis Group II (periodontitis) ligature-induced periodontitis •Group III (HA) ligature-induced periodontitis with HA administration Group III (HA) ligature-induced periodontitis with HA administration •Group IV (PRP) ligature-induced periodontitis with PRP administration Group IV (PRP) ligature-induced periodontitis with PRP administration •Group V (HA + PRP) ligature-induced periodontitis with both HA and PRP administration Group V (HA + PRP) ligature-induced periodontitis with both HA and PRP administration Induction of periodontitis Animals of groups II, III, IV, and V were applied to periodontitis induction according to the protocol of Wichienrat et al.24 In all animals, a 3-0 silk ligature was placed and secured at the level of the gingival sulcus in the lower right first molar. A ligature was knotted submarginally for 2 weeks24 to act as a retentive factor for dental plaque. Removal of the silk ligature and probing pocket depth were evaluated at baseline, after ligature removal, and after 2 weeks of treatment for all groups.10 Periodontitis was clinically observed as gingival swelling and redness, with a tendency toward bleeding, and probing pocket depth around the ligated lower right first molar.25 Formulation of hyaluronic acid gel A low-molecular-weight hyaluronic acid (HA) formulation was prepared to achieve optimal rheological properties suitable for injection via a fine needle while maintaining sufficient viscosity for adherence within the periodontal pocket. Briefly, pharmaceutical-grade hyaluronic acid powder (molecular weight ≈ 150–300 kDa; Advent Co.) was dissolved in distilled water under magnetic stirring at room temperature to obtain a 3% (W/V) HA solution. After freeze-drying the prepared hydrogel sample, FTIR and SEM images were characterized. The formulated HA gel was used alone or mixed with activated PRP for groups III and V, respectively. PRP preparation PRP was prepared using a double-spin method, with modifications based on the previously performed procedures.26 Blood was collected by puncturing the hearts immediately after the male rats were humanely euthanized, with 7 rats used in the first week and 8 rats in the second week. The blood was stored in 3.8% sodium citrate anticoagulant tubes. The process was performed under sterile conditions in a Biobase vertical laminar-flow cabinet (Biobase Model BBS V1300). To prevent platelet lysing and preserve their ability to excrete growth factors, the samples were centrifuged at 1000 rpm for 10 min to separate red blood cells (RBCs), white blood cells (WBCs), and platelets. The upper portion of the supernatant, containing plasma and platelets, was collected into fresh tubes and centrifuged again at 2000 rpm for 10 min. The supernatant was discarded, and the lower 20% of the plasma, rich in platelets, was retained as PRP. The remaining 80% of plasma was discarded and stored separately as platelet-poor plasma (PPP). The platelet pellet was resuspended to prepare PRP, which was used within 6 h. Before administration, 50 μL of 10% calcium chloride (Sigma Aldrich, USA) (0.025 mol/L) was added to 3 mL of PRP for activation. The activated PRP was then administered immediately by injection. Treatment administration •Rats in group III were injected with the formulated HA (0.5 ml) locally in the periodontium of the lower right first molar once a week (at the start of each week after periodontitis induction).27 Rats in group III were injected with the formulated HA (0.5 ml) locally in the periodontium of the lower right first molar once a week (at the start of each week after periodontitis induction).27 •Rats in group IV were injected with 0.5 mL of freshly prepared activated PRP locally in the periodontium of the lower right first molar once a week (at the start of each week after periodontitis induction).28 Rats in group IV were injected with 0.5 mL of freshly prepared activated PRP locally in the periodontium of the lower right first molar once a week (at the start of each week after periodontitis induction).28 •1 ml of activated PRP was added to 25 mg of HA. After that, Rats in group V were injected with 0.5 ml of the mixed solution locally into the periodontium of the lower right first molar once a week (at the start of each week after periodontitis induction)29 1 ml of activated PRP was added to 25 mg of HA. After that, Rats in group V were injected with 0.5 ml of the mixed solution locally into the periodontium of the lower right first molar once a week (at the start of each week after periodontitis induction)29 •The treatment started after periodontitis induction through ligation for 14 days (at the start of each week after periodontitis induction). Thus, all rats in the experimental groups received two injections throughout the two weeks. The treatment started after periodontitis induction through ligation for 14 days (at the start of each week after periodontitis induction). Thus, all rats in the experimental groups received two injections throughout the two weeks. Biochemical analysis Plasma samples from blood were analyzed to quantify TNF-α and IL-1β levels in all animal groups. These analyses were performed via enzyme-linked immunosorbent assay (ELISA) kits obtained from Elabscience, USA (Catalog Nos: E-CL-R0019 and E-EL-R0012).30 Animal euthanization After 2 weeks of periodontitis induction, all rats were euthanized. Animals were first anesthetized using an overdose of intraperitoneal ketamine (100 mg/kg) and xylazine (10 mg/kg) to induce deep anesthesia. Once the absence of reflexes and respiration was confirmed, euthanasia was completed via cervical dislocation, ensuring rapid and irreversible death.31 Then, the lower posterior teeth with their periodontium specimens were processed for histological and ultrastructural evaluation. Histological evaluation The lower teeth and the surrounding periodontium were prepared for light microscopy (LM) to investigate histological alterations in tissue structure between the groups. Samples were fixed in 10% neutral buffered formalin, decalcified, and embedded in paraffin blocks according to standard procedures. After sectioning the samples into five μm sections, a hematoxylin and eosin stain (H&E) was used.32 Scanning electron microscopy evaluation After carefully removing the soft tissues, the bone surfaces of all groups were examined using an SEM (Scanning Electron Microscope) Model Quanta 250 FEG (Field Emission Gun). The samples were then carefully dried and gold-plated using a JFC-1100E-IEOL ion sputtering evaporator. They were then fixed on an SEM (JEOL-JSM-5200LV, Tokyo, Japan) to investigate the buccal surface of the bone and molar area. Statistical analysis Data collected for TNF-α and IL-1β were entered into IBM SPSS Statistics version 20.0 and analyzed. (Armonk, NY: IBM Corp). The Shapiro-Wilk test was used to assess the normality of the distributions of the variables. ANOVA was used to compare the three studied groups, followed by a Post Hoc test (Tukey) for pairwise comparisons. The significance of the results obtained was judged at the 5% level. Statistical probability will predict the likelihood of the different outcomes of the three experimental groups. Results Characterization of the formulated HA was performed using the following analytical techniques Rheological testing Viscosity and flow behavior were assessed using a Brookfield DV-II + Pro RV rotational viscometer (AMETEK Brookfield, Middleboro, MA, USA) with spindle RV-3 at a rotational speed of 20 rpm. Approximately 25 mL of the formulation was placed, ensuring correct spindle immersion. The temperature was maintained at 25 ± 0.5 °C1, readings were taken in triplicate and reported in centipoise (cP). The 3% HA gel exhibited a viscosity of 1850 ± 35 cP, facilitating extrusion through a 27G needle without clogging. Scheme 1 shows the observed viscosity at 3% concentration.33 The formulated 3% hyaluronic acid (HA) gel was extruded through a 27-gauge syringe needle. Fourier transform infrared spectroscopy (FTIR) The chemical structure of the HA gel was analyzed by FTIR spectroscopy (PerkinElmer, USA), in the range of 4000–400 cm−1 (Fig. 1). The spectrum showed characteristic absorption bands at ∼3300 cm−1 (O–H stretching), ∼2900 cm−1 (C–H stretching), and ∼1600 cm−1 (asymmetric stretching of carboxylate group COO−), confirming the presence of hydroxyl and carboxyl functional groups. Peaks at ∼1375 cm−1 correspond to the N-acetyl group, while bands near 1040 cm−1 represent C–O–C stretching vibrations. These results indicate that the main functional groups of HA were preserved during formulation, with no detectable chemical degradation. FTIR analysis of freeze-dried hydrogel HA. Morphological examination The microstructure of the freeze-dried HA gel was examined using SEM (JEOL-JSM-5200LV, Tokyo, Japan). Samples were sputter-coated with gold and imaged at an accelerating voltage of 10–15 kV. The morphological study of the formulated HA is illustrated in Fig. 2. The SEM micrograph revealed a sponge-like matrix with variable pore sizes. This porous architecture is beneficial for absorbing and retaining fluids, such as tissue exudate from inflamed periodontal sites, and for holding bioactive components, such as platelet-rich plasma (PRP), when delivered in the PDL pocket. Such fluid retention can help maintain a moist environment that supports PDL healing and allows sustained local delivery of therapeutic agents. Image 2B showed a more organized, layered (lamellar) structure. Elongated spaces that appear like tunnels or slits are visible instead of pores. These microchannels allow cells (like fibroblasts or ligament progenitor cells) to migrate and proliferate. SEM images for the prepared hyaluronic acid hydrogel. Clinical observations During the experimental period, the general behavior of the rats in the five groups was observed. They exhibited normal behavior and showed no apparent change in body weight. All animal treatment groups healed without significant complications and were sacrificed as scheduled. There was no rat dropout during the experiment. Light microscopic results Dento-gingival junction The dento-gingival junction of group I showed a relatively normal gingival epithelium with narrow parallel epithelial ridges overlying the gingival CT and intact junctional epithelium at the base of the gingival sulcus, which was found at the coronal area (Fig. 3-A1). In groups II and III, the gingival epithelium showed loss of epithelial ridges, and the base of the periodontal pocket deepened to the apical and middle areas in group III. Both groups showed loss of the junctional epithelium (Fig. 3-A2 and A3). Group IV showed thick, short rete pegs overlying thick fibrous CT and the base of the periodontal pocket in the middle area of the root with nearly normal junctional epithelium (Fig. 3, Fig. 4). In group V, the gingival epithelium showed nearly normal thin short rete pegs overlying dense fibrous CT and base of the periodontal pocket at the coronal area with junctional epithelium at the healing stage (Fig. 3, Fig. 4, Fig. 5). Light photomicrographs of molar teeth and their periodontium for all groups. (A1-A5) showing the dento-gingival junction of all groups. (A1) (group I) showing a relatively normal gingival epithelium (GE) with narrow parallel epithelial ridges (curved arrow) overlying the gingival CT and intact junctional epithelium (arrowhead) at the base of the gingival sulcus (arrow). Note that the sulcus base is at the coronal area (arrow). (A2 & A3) (group II and III respectively) The gingival epithelium depicts the partial loss of the epithelial ridges (curved arrow), and the base of the periodontal pocket shifted to the apical area (arrow) at A2 and to the middle area at A3 (arrow). Note that junctional epithelium (arrowhead) is lost in A2 and A3. (A4) (group IV) The gingival epithelium shows thick short rete pegs (curved arrow) overlying thick fibrous CT and base of the periodontal pocket at the middle area of the root (arrow) with recovered junctional epithelium (arrowhead). (A5) (group V) gingival epithelium shows recovered thin short rete pegs (curved arrow) overlying dense fibrous CT and base of the periodontal pocket at the coronal area (arrow) with junctional epithelium at the healing stage (arrowhead). (B1-B5) showing the interdental papillae of all groups. (B1) (group I) showing a relatively normal interdental papilla (P), regular well-organized transseptal PDL fibers with average direction (double-head arrow) overlying the crest of alveolar bone (AB). (B2, B3, and B4) (groups II, III, and IV, respectively) showed migration of the interdental papilla and PDL fibers to the apical area with a loss of interdental bone. Note that PDL fibers are showing widening and degenerating (∗). Notice the presence of areas of root resorption (arrows) in B3. (B5) (group V) shows a relatively normal interdental papilla (P), with regular well-organized transseptal PDL fibers in an average direction (double-head arrow). (C1-C5) showing the alveolar bone of all groups. (C1) (group I) shows a regular bone surface lined by a continuous layer of plumb osteoblasts (arrows). Standard size, number, and distribution of osteocytes (arrowheads) inside a dense bone trabecula. Note: the deeply stained resting lines (curved arrow). (C2) (group II) depicts thin, disorganized bone trabeculae with wide, inflamed bone marrow (BM). The osteocyte's lacunae appear large and empty (arrowheads). Note: The deeply stained resting lines (curved arrow), widened and degenerated PDL fibers (∗), and the area of osteoclast clusters (arrow). (C3 and C4) (group III and IV, respectively) depict the alveolar bone containing osteocytes lacunae, which appear large and empty or contain dense nuclei (arrowheads). Numerous deeply stained reversal lines (curved arrows) and large bone marrow space (BM), as well as the widening and degeneration of PDL fibers (∗), are also depicted. (C5) (group V) shows well-vascularized bone marrow spaces, well-organized PDL fibers, numerous bone reversal lines (curved arrows), and osteocyte lacunae appeared large with apparent nuclei (arrowhead) and regular PDL fibers. (H& E stain, A1-C5 X 400). Scanning electron micrographs of buccal cortical plate of all groups. (A) (group I) shows intact alveolar bone crest (star) with an average level of between 1st and 2nd molars at CEJ level (arrow), typical architecture of buccal cortical plate, and generalized smooth surface topography (S) with smooth round nutritive canals (curved arrow). (B and C) (group II) depicts severe resorption of the alveolar bone crest (stars) between the 2 M and the buccal cortical plate with a generalized severe roughened (R) surface and apical resorption of the alveolar bone (arrow). Notice the severe loss of inter-radicular bone (∗) at C. (D) (group III) shows partial recovery of the alveolar bone crest (star) between the 2 M and buccal cortical plate with an alternative smooth (S) and roughened (R) surface areas. Notice the widened irregular nutritive canals (curved arrow) and almost the coronal third of the first molar root is exposed. (E) (group IV) displays complete alveolar bone crest (star) recovery between the 1st and 2nd molars. The buccal cortical plate shows less smooth (S) and large roughened (R) surface areas. Notice almost the coronal third of the first molar root is exposed. (F) (group V) shows the complete recovery of the alveolar bone crest (star) between the 1st and 2nd molars. The buccal cortical plate shows alternative, large, smooth (S), and less roughened (R) surface areas and almost the coronal third of the first molar root is exposed. (SEM, original magnification; A, D, E & F X 75 and B & C X 150). Effect of HA and RPR on TNF-α and IL-1β Results are expressed as mean blood lead level ± SEM. Interdental papillae The interdental papillae of group I showed relatively normal interdental papillae, regular, well-organized transseptal PDL fibers with average direction overlying the crest of the alveolar bone (Fig. 3-B1). Groups II, III, and IV showed migration of the interdental papilla and PDL fibers to the apical area, resulting in a loss of interdental bone. Also, the PDL fibers showed areas of widening and degeneration, and multiple regions of root resorption were observed in group III (Fig. 3-B2, B3, and B4). Group V showed a relatively normal interdental papilla, with regular, well-organized transseptal PDL fibers in an average direction (Fig. 3, Fig. 4, Fig. 5). Alveolar bone Group I showed a normal bone surface lined by a continuous layer of plump osteoblasts. The dense bone trabecula depicted a standard size, number, and distribution of osteocytes, as well as deeply stained resting lines (Fig. 3-C1). Group II depicted thin, disorganized bone trabeculae with comprehensive, inflamed bone marrow. The osteocyte's lacunae appeared large and empty. Also, the deeply stained reversal lines widened and degenerated PDL fibers, and the area of osteoclast clusters was easily depicted (Fig. 3-C2). Groups III and IV depicted the alveolar bone containing osteocytes' lacunae, which appeared large and empty or contained dense nuclei. Numerous deeply stained reversal lines and ample bone marrow space, as well as the widening and degeneration of PDL fibers, were also depicted (Fig. 3-C3 and C4). Group V showed well-vascularized bone marrow spaces, well-organized PDL fibers, numerous bone reversal lines, and osteocyte lacunae that appeared large with apparent nuclei and regular PDL fibers (Fig. 3, Fig. 4, Fig. 5). Scanning electron microscopic results To better understand the variations within the experimental groups, we captured an SEM image of a regular, intact buccal surface of the bone and the molar area. Group I showed an intact alveolar bone crest, with an average level between the 1st and 2 nd M at the CEJ level. The typical architecture of the buccal cortical plate and generalized smooth-surface topography with smooth, round nutritive canals were also depicted (Fig. 4-A). Group II depicted severe resorption of the alveolar bone crest between the 2 M and the buccal cortical plate with a generalized severe roughened surface and apical resorption of the alveolar bone, in addition to a severe loss of inter-radicular bone (Fig. 4- B and C). Group III partially recovered the alveolar bone crest between the 2 M and the buccal cortical plate with alternative smooth and roughened surface areas with widened, irregular nutritive canals (Fig. 4-D). Group IV displayed complete alveolar bone crest recovery between the 1st and 2nd molars. The buccal cortical plate shows alternative, less-smooth, more-roughened surface areas (Fig. 4-E). Group V completely recovered the alveolar bone crest between the 1st and 2nd molars. The buccal cortical plate showed large, smooth, less roughened surface areas (Fig. 4-F). Biochemical results As shown in Table 1, the levels of TNF-α and IL-1β were significantly different among the studied groups (p < 0.001 for both) (Fig. 5). In the periodontitis group, TNF-alpha (269.3 ± 21.50 pg/ml) and IL-1β (345 ± 32.79 pg/ml) were markedly elevated compared to the control group (122.3 ± 11.24 pg/ml and 155 ± 13.23 pg/ml, respectively; p < 0.001). Treatment with HA, PRP, and their combination significantly reduced both markers compared to the periodontitis group (p < 0.05). While HA and PRP individually showed similar reductions in TNF-alpha (174.7 ± 12.66 and 170.3 ± 9.07 pg/ml, respectively; p = 0.995) and IL-1β (279.7 ± 15.50 and 262.3 ± 11.68 pg/ml, respectively; p = 0.821), the combination of HA and PRP was more effective, particularly in lowering IL-1β (225.7 ± 19.14 pg/ml), with a significant difference compared to HA alone (p = 0.048). These findings suggest that HA and PRP have therapeutic effects on inflammatory markers, with the combination therapy showing potential synergistic benefits, especially in reducing IL-1β levels. Table 1Comparison between the different studied groups according to TNF-alpha and IL-1β.Table 1Control (n = 8)Periodontitis (n = 8)HA (n = 8)PRP (n = 8)HA + PRP (n = 8)FpTNF-alpha (pg/ml)Mean ± SD.122.3 ± 11.24269.3a ± 21.50174.7ab ± 12.66170.3ab ± 9.07151.7ab ± 12.50pcontrol<0.001∗0.007∗0.013∗0.15346.334∗0.001∗Sig. bet. grps.p1 < 0.001∗,p2 < 0.001∗,p3 < 0.001∗,p4 = 0.995,p5 = 0.330,p6 = 0.514IL-1β (pg/ml)Mean ± SD.155 ± 13.23345a ± 32.79279.7ab ± 15.50262.3ab ± 11.68225.7abc± 19.14pcontrol<0.001∗<0.001∗<0.001∗0.010∗36.901∗0.001∗Sig. bet. grps.p1 = 0.017∗,p2 = 0.003∗,p3 < 0.001∗,p4 = 0.821,p5 = 0.048∗,p6 = 0.238SD: Standard deviation, F: F for One-way ANOVA test, pairwise comparison between every 2 groups was done using Post Hoc Test (Tukey).p: p-value for comparing the studied groups.pcontrol: p-value for comparing between Control and each other group.p1: p-value for comparing between Periodontitis and HA, p2: p-value for comparing Periodontitis and PRP, p3: p-value for comparing between Periodontitis and HA + PRP, p4: p-value for comparing between HA and PRP, p5: p-value for comparing between HA and HA + PRP, p6: p-value for comparing between PRP and HA + PRP.∗: Statistically significant at p ≤ 0.05, a: significant with Control, b: significant with Periodontitis, c: significant with HA, d: significant with PRP. Comparison between the different studied groups according to TNF-alpha and IL-1β. SD: Standard deviation, F: F for One-way ANOVA test, pairwise comparison between every 2 groups was done using Post Hoc Test (Tukey). p: p-value for comparing the studied groups. pcontrol: p-value for comparing between Control and each other group. p1: p-value for comparing between Periodontitis and HA, p2: p-value for comparing Periodontitis and PRP, p3: p-value for comparing between Periodontitis and HA + PRP, p4: p-value for comparing between HA and PRP, p5: p-value for comparing between HA and HA + PRP, p6: p-value for comparing between PRP and HA + PRP. ∗: Statistically significant at p ≤ 0.05, a: significant with Control, b: significant with Periodontitis, c: significant with HA, d: significant with PRP. Discussion One important sequela of periodontitis is bone resorption and subsequent tooth loss. Thus, periodontitis treatment is vital to preserve the tooth.2,6 Periodontal regeneration remains a complex and unsolved problem, requiring maximum restoration of the gingival epithelium, CT, PDL, and alveolar bone. Various regenerative strategies have been proposed for treating periodontitis.15 In the present study, a 3% low-molecular-weight hyaluronic acid (HA) gel was formulated for periodontal injection. While several commercially available HA products exist for intraoral use, many are supplied at relatively low concentrations (typically ≤1%), such as Gengigel® and the formulation used at 0.8% concentration have demonstrated moderate clinical improvements in probing depth and microbial reduction when used as an adjunct to scaling and root planning, these low-concentration gels may lack sufficient viscosity for prolonged retention in the periodontal pocket. In contrast, our 3% low-molecular-weight HA gel provides a significantly higher polymer content, resulting in enhanced scaffold stability and prolonged residence time. Higher HA concentrations have been linked to stronger anti-inflammatory responses and enhanced hydration. By offering both syringe injectability and superior retention, the proposed formulation addresses the clinical limitations of dilute HA products, which may be rapidly cleared from the application site.34 Investigating the pathologic mechanisms of infectious diseases, such as periodontitis, has been done using animal models. Histologically based functions of bacteria or other factors in periodontitis can be effectively performed in small animals such as rats, providing sufficient preclinical and statistical relevance. The severity of periodontitis has been evaluated using ligature-induced periodontitis in primates, dogs, and rats.35 In addition, ligature-induced periodontitis is less expensive, requires less animal manipulation, and has a shorter development time.36 Histologically based functions of bacteria or other factors in periodontitis can be effectively performed in small animals such as rats, providing sufficient preclinical and statistical relevance. It was concluded that a 3-0 silk ligature resulted in the lowest rate of ligature loss.24 In experimental and clinical settings, 14 days after periodontitis induction provides insights into therapeutic outcomes and helps refine protocols before moving to longer-term studies. The 14-day treatment window is commonly used in animal models because it yields reproducible results that are comparable across studies. This allows researchers to evaluate various interventions under controlled conditions and provides a standardized method for evaluating periodontal disease progression and treatment effectiveness. In addition, they stated that the 2-week period could serve as a window for testing regenerative materials and/or treatment modalities in ligature-induced periodontitis models in rats. Thus, all rats were euthanized after 2 weeks of periodontitis induction.24 The histological outcomes under LM in the present study's group I showed relatively normal gingival epithelium, a normal interdental papilla, and a regular bone surface. This result agrees with previous studies about the typical structure of alveolar bone in rats 37, 38, 39, 40. After two weeks of the ligature placement, group II showed the typical histological signs of chronic periodontitis such as loss of the epithelial ridges, apical shifting of the base of the periodontal sulcus and interdental papilla, loss of the junctional epithelium, loss of interdental bone, widening and degeneration of PDL fibers, root resorption, and inflammation (with inflammatory cell infiltrates) disorganized bone trabeculae. These results agreed with similar previous experimental studies.41,42 However, group III (HA-treated) showed the same histological features as the periodontitis group regarding the dento-gingival junction and interdental papillae. However, there is a minor improvement regarding the alveolar bone, which showed numerous large osteocyte lacunae, deeply stained reversal lines, and ample bone marrow space. This indicates that tissue adaptation and bone remodeling cause the appearance of the reversal lines that separate the old bone and the newly deposited bone.43 The considerable bone marrow space includes the organization of bone marrow activities and bone surface activities, which allow for the combination of osteoblastogenesis, which appears as the large osteocyte lacunae, and bone remodeling.44 In group IV (PRP-treated), the interdental papillae and alveolar bone showed nearly the same results as in group III. However, a moderate recovery regarding the dento-gingival junction was depicted as thick, short rete pegs overlying thick fibrous CT and the base of the periodontal sulcus in the middle area of the root with recovered junctional epithelium. These features indicate the initial regeneration of the pocket epithelium.45 Group V (HA + PRP) showed gingival epithelium with thin, short rete pegs overlying dense fibrous CT, and the periodontal pocket base at the coronal area with junctional epithelium at the healing stage. Also, relatively normal interdental papilla, with regular well-organized transseptal PDL fibers, well-vascularized bone marrow spaces, well-organized PDL fibers, numerous bone reversal lines, and osteocyte lacunae that appeared large with apparent nuclei and regular PDL fibers. All these histological features are considered the best recovery criteria.46 Generally, the SEM results are consistent with the LM results. The smooth and roughened surface areas.47 TNF-α and IL-1β are vital pro-inflammatory cytokines involved in the pathogenesis of periodontitis and in the impairment of wound healing and regeneration. The results of the present study showed a significant elevation of the TNF-α and IL-1β in group II and a significant decrease in group V compared with group I. However, the difference between groups III and IV was insignificant. These results confirmed the histological features in all groups regarding signs of inflammation in group II compared with group I. Also, there were signs of the highest recovery in group V and a slight recovery in groups III and IV compared with group II. Increased synthesis of TNF-α and IL-1β triggers the release of additional inflammatory mediators, incites tissue destruction through MMP activation, and promotes osteoclast activity in bone resorption. Therefore, high expression would increase inflammation and tissue destruction. Periodontitis leads to colonization of the gingival sulcus by periodontopathic bacteria, increasing the permeability of gingival capillaries and the chemotaxis of inflammatory cells. After that, a periodontal inflammatory response occurs under the control of primary mediators such as prostaglandins and interleukins-1, 6, 8, and 10, and TNF-α.48 This shows elevated TNF-α in group II compared with group I, and its decrease in the remaining groups. Notably, HA displays anti-inflammatory properties. It implements hunting actions by clearing the inflammatory mediators from the inflammation site.49 It also modifies the cellular and extracellular micro- and macroenvironments, in addition to its bacteriostatic activity.50 Furthermore, HA is a key component of the periodontal extracellular matrix, including gingiva, PDL, alveolar bone, and cementum. It plays a crucial role in tissue formation and repair, particularly within the PDL matrix. It facilitates cell migration, adhesion, and differentiation, and enhances the expression of mineralized tissue-specific genes in cementoblasts, which are crucial for PDL.51 This explains the results of Group III. Also, PRP delivers a rapid source of growth factors (Table 2) to the injection site.52 These factors were found to have a positive effect on periodontal healing and regeneration10,53, 54, 55. Notably, platelets in PRP contain granules containing numerous active biomolecules. When activated, these biomolecules are released, triggering the body's natural healing process. Platelets play a crucial role in wound healing and soft tissue.56 Upon activation, they release various growth factors, fibrin, fibronectin, and vitronectin, which provide a structural matrix for CT and serve as adhesion molecules to facilitate cell migration. As a result, they are vital to cell proliferation, collagen production, and osteoid development.57,58 The combination of PRP and HA offers several benefits for wound healing, including faster recovery compared to PRP alone as a bio-stimulator or HA alone as a scaffold. The combination of both PRP and HA is anticipated to promote quicker wound healing. HA also induces the release of growth factors from PRP.59,60 In addition, PRP provides a concentrated source of growth factors, such as platelet-derived growth factor (PDGF) and transforming growth factor beta (TGF-β), which stimulate cell proliferation, differentiation, and angiogenesis. Together, these properties can accelerate recovery and improve tissue functionality.61 However, the exact mechanisms underlying this synergistic effect remain unclear. For instance, how HA might influence the release, stability, or activity of PRP-derived growth factors, or how their combined actions modulate inflammation and tissue remodeling, remains unclear. Detailed mechanistic studies are essential to provide a deeper understanding of these interactions and to validate the observed clinical efficacy at the molecular and cellular levels.62,63 This explains the results of Group IV. Future studies should include analysis of inflammatory markers in both blood and gingival tissue to achieve a more comprehensive understanding of systemic and localized inflammatory responses. Furthermore, potential future uses of platelet concentrates involve the possibility of combining drugs with them to ensure controlled drug release at the surgical site involved.64 Table 2Growth factors in PRP and their biological functions (Pavlovic et al., 2016).Table 2NameAbbreviationFunctionPlatelet-derived growth factorPDGFEnhances collagen synthesis, proliferation of bone cells, fibroblast chemotaxis, proliferative activity, and macrophage activationTransforming growth factor βTGF-βEnhances synthesis of type I collagen, promotes angiogenesis, stimulates chemotaxis of immune cells, inhibits osteoclast formation and bone resorptionVascular endothelial growth factorVEGFStimulates angiogenesis, migration, and mitosis of endothelial cells, increases permeability of the vessels, stimulates chemotaxis of macrophages and neutrophilsEpidermal growth factorEGFStimulates cellular proliferation, differentiation of epithelial cells, and promotes cytokine secretion by mesenchymal and epithelial cellsInsulin-like growth factorIGFPromotes cell growth, differentiation, and recruitment in bone, blood vessels, skin, and other tissues, stimulates collagen synthesis together with PDGFFibroblast growth factorFGFPromotes proliferation of mesenchymal cells, chondrocytes, and osteoblasts, stimulates the growth and differentiation of chondrocytes and osteoblasts Growth factors in PRP and their biological functions (Pavlovic et al., 2016). Conclusion Treatment modalities using HA or PRP could improve periodontitis healing. However, the combined administration of HA and PRP resulted in accelerated periodontal tissue healing. This might be due to the intensifying collection of both adjunctive anti-inflammatory and regenerative properties. Further studies are needed to evaluate this combination, and clinical translation in future research is also needed to evaluate the study. Study limitations While this study focused on TNF-α and IL-1β as primary indicators of inflammation, future research should consider analyzing additional markers, such as IL-6 and matrix metalloproteinases (MMPs), to provide a more holistic view of the inflammatory cascade in periodontitis. Also, future studies should include direct measurement of inflammatory markers in the gingival tissues. This would enhance the specificity of the inflammatory response and provide more localized insights. Also, further exploration of the correlation between systemic and local markers is essential to understand how well blood markers predict tissue-specific inflammation in periodontal disease. Ethics approval The present investigation was conducted in adherence to the protocols established by the Research Ethics Committee of the Faculty of Dentistry, Pharos University in Alexandria, under Ethical Code 189. Consent for publication Not applicable. Author contributions Wafaa Yahia Alghonemy. Study conception and design, clinical procedure, data collection, sharing in writing, revising the manuscript, shooting, revising histological results and analysis, editing, and reviewing the final manuscript. Omnia M Abdelfatah: Study conception and design, histological analysis, data collection, shared in writing and revising the manuscript. Nevien M. Ahmed, Study conception and design, material preparation and injection, data collection, sharing in writing, and revising the manuscript. Abeer A. Abou Samra and Asmaa M. Abd El-aziz studied conception and design, material preparation and injection, data collection, and manuscript sharing and revision. Eman M Salem contributed to clinical procedures, writing and revising the manuscript, shooting and revising histological results and analysis, and editing and reviewing the manuscript. All authors reviewed the results and approved the final version of the manuscript. Clinical trials Not applicable. Ethical approval All experimental procedures were conducted according to the ARRIVE guidelines and the Institutional Animal Care and Use Committee (IACUC) regulations. The experimental protocol was reviewed and approved by the Research Ethics Committee of the Faculty of Dentistry, Pharos University, under ethical code PUA02202402253192, ensuring that all procedures minimized animal suffering and adhered to national and institutional standards for the care and use of laboratory animals. Patient approval N/A. Funding No funding was provided to the authors by any organizations. Declaration of competing interest The authors declared no conflict of interest relevant to this article. Acknowledgments Not applicable. Contributor Information Wafaa Yahia Alghonemy, Email: Wafaa_yehya@dent.tanta.edu.eg. Nevien M. Ahmed, Email: Nevien.mahmoud@pua.edu.eg. Abeer A. Abou Samra, Email: abeer.abousamra@pua.edu.eg. Omnia M. Abdelfatah, Email: omnia.magdy@pua.edu.eg. Rania A. Hanafy, Email: Rania.Hanafy@pua.edu.eg, rania.hanafy@alexu.edu.eg. Asmaa M. Abd El-Aziz, Email: aabdelaziz@srtacity.sci.eg. Eman M. Salem, Email: Eman.salem@pua.edu.eg. Data availability Data generated during the current study is available from the corresponding author upon reasonable request. References Associated Data Data Availability Statement Data generated during the current study is available from the corresponding author upon reasonable request.